AXA S.A. - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 17 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AXA S.A. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$562,000
-70.9%
283,820
-49.9%
0.00%
-80.0%
Q3 2021$1,931,000
-78.7%
566,207
-49.1%
0.01%
-61.5%
Q2 2021$9,058,000
+32.5%
1,111,510
+100.0%
0.01%
-38.1%
Q1 2021$6,836,000
-32.1%
555,778
+0.8%
0.02%
-34.4%
Q4 2020$10,070,000
+17.5%
551,476
+0.4%
0.03%
+3.2%
Q3 2020$8,572,000549,1540.03%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,379,843$11,246,0002.62%
Novo Holdings A/S 2,361,229$19,244,0000.85%
Ally Bridge Group (NY) LLC 401,747$3,274,0000.81%
SECTORAL ASSET MANAGEMENT INC 640,714$5,222,0000.42%
FRAZIER MANAGEMENT LLC 550,000$4,483,0000.41%
TFG Asset Management GP Ltd 750,000$6,113,0000.33%
Eventide Asset Management 2,485,656$19,757,0000.26%
AXA S.A. 1,111,510$9,058,0000.01%
Woodline Partners LP 25,932$211,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 2,001,951$16,315,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders